Летрогратис

Летрогратис (Letrozole) is an oral aromatase inhibitor used primarily for hormone receptor-positive breast cancer therapy. This non-steroidal medication reduces estrogen production in postmenopausal women. Suitable for prescription-based treatment regimens.

Letrozole is commonly prescribed to treat hormone receptor-positive breast cancer in postmenopausal women. It works by lowering estrogen levels, which can slow or stop the growth of certain cancer cells. The medication is also used off-label for fertility treatments in ovulation induction protocols. Patients often ask, 'what is Letrozole used for' in both cancer and reproductive health contexts.

Letrozole may cause mild to moderate side effects such as hot flashes, joint pain, or fatigue. Some users report bone density changes or mood fluctuations during treatment. These effects vary by individual and are typically monitored by a healthcare provider. Most symptoms are temporary and manageable with supportive care.

Keep Letrozole in a cool, dry place away from direct sunlight. Store at room temperature and ensure the container is tightly sealed. Avoid exposure to moisture or extreme heat. Always follow the handling instructions provided with the medication to maintain its stability and effectiveness.

Letrozole may interact with other medications, including certain antidepressants, hormone therapies, or CYP enzyme inhibitors. Alcohol consumption should be limited as it may exacerbate side effects like dizziness or nausea. Always inform your healthcare provider about all medications and supplements you are taking before starting Letrozole.